UK markets closed

Ovid Therapeutics Inc. (OVID)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.2000-0.0100 (-0.31%)
As of 01:24PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.21-0.21-0.84-0.28
Low estimate-0.24-0.24-0.96-1.01
High estimate-0.17-0.18-0.731.42
Year ago EPS-0.19-0.18-0.74-0.84
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate50k60k240k47.5M
Low estimateN/AN/AN/A870k
High estimate170k190k820k179.4M
Year ago sales66k75k392k240k
Sales growth (year/est)-24.20%-20.00%-38.80%19,691.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.17-0.2-0.19-0.05
Actual EPS-0.19-0.18-0.16-0.22
Difference-0.020.020.03-0.17
Surprise %-11.80%10.00%15.80%-340.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.21-0.21-0.84-0.28
7 days ago-0.21-0.21-0.84-0.28
30 days ago-0.22-0.22-0.86-0.23
60 days ago-0.18-0.19-0.66-0.04
90 days ago-0.18-0.19-0.66-0.04
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesOVIDIndustrySector(s)S&P 500
Current qtr.-10.50%N/AN/AN/A
Next qtr.-16.70%N/AN/AN/A
Current year-13.50%N/AN/AN/A
Next year66.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A